10 days ago
BMRN
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Analyst Ranking
Top 2%
#75 out of 5164 analysts
Average Return
+42.48%
Win Rate
58%75 out of 130
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +778.51% | $33.55 | $294.74 | 2025-03-02 - 2025-12-31 | Strong Buy |
Verona Pharma PLCVRNA | +548.82% | $14.46 | $93.82 | 2024-06-27 - 2025-06-27 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-01 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-26 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-28 - 2024-03-28 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
18 days ago
WVE
25 days ago
PRAX
2 months ago
ALKS
2 months ago
BMRN
3 months ago
PRAX
4 months ago
ARGX
5 months ago
PTCT
9 months ago
CORT
10 months ago
AXSM
a year ago
CRSP
a year ago
AXSM
a year ago
ARGX
a year ago
AXSM
a year ago
VRNA
a year ago
WVE
a year ago
CPRX
a year ago
ARGX
a year ago
CRMD
a year ago
VRNA
a year ago
CORT
a year ago
CPRX
a year ago
ARGX
2 years ago
VRNA
2 years ago
ARGX
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $100.00 | +68.27% | Maintains | 10 days ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $50.00 | +194.12% | Maintains | 18 days ago |
Praxis Precision Medicines IncPRAX | 7 | Strong Buy | $500.00 | +69.64% | Maintains | 25 days ago |
Alkermes PLCALKS | 3 | Strong Buy | $55.00 | +96.57% | Maintains | 2 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $14.00 | +55.73% | Reiterates | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $90.00 | +291.30% | Maintains | 2 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $44.00 | +45.02% | Initiates Coverage On | 4 months ago |
Argenx SeARGX | 13 | Strong Buy | $918.00 | +9.16% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $490.00 | +8.08% | Maintains | 5 months ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $86.00 | +13.22% | Maintains | 5 months ago |
Sage Therapeutics IncSAGE | 8 | Hold | $9.00 | +3.69% | Maintains | 7 months ago |
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +113.19% | Reiterates | 8 months ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +77.07% | Maintains | 9 months ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | +331.03% | Maintains | 9 months ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | +9.51% | Maintains | 10 months ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | +128.83% | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | +372.44% | Initiates Coverage On | a year ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | -46.68% | Reiterates | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +183.69% | Initiates Coverage On | a year ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $200.00 | N/A | Reiterates | 2 years ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 4 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 5 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.